The model is available in PEtab format 50 at All model analyses, parameter estimation and identifiability analysis have been carried out using the dMod 51 package for R
According to statistics, there are currently approximately 50 million people living with AD worldwide, and this number is expected to increase to 152 million by 2050 as the population ages, making it a major challenge for global public health ( The glucagon-like peptide-1 receptor (GLP-1R) is a key target for diabetes mellitus (DM) treatment, and GLP-1R agonists are pharmaceutical compounds employed in the treatment of DM
Reported mild effects include injection site irritation, headache, or temporary fatigue
A cross-sectional study of children 26 years of age concluded that frequent APAP use in these patients was associated with the formation of a wheeze or asthma (Nguyen et al., 2013)
Liver disease: Due to rare reports of hepatotoxicity, patients with compromised liver function should seek medical advice before using ashwagandha
[3] Both medications are intended as adjuncts to a comprehensive weight management programme that includes dietary modification, increased physical activity, and behavioural support
